These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7503249)

  • 1. Catecholamine response to chronic ANG II infusion and its role in myocyte and coronary vascular damage.
    Henegar JR; Brower GL; Kabour A; Janicki JS
    Am J Physiol; 1995 Nov; 269(5 Pt 2):H1564-9. PubMed ID: 7503249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANG II-related myocardial damage: role of cardiac sympathetic catecholamines and beta-receptor regulation.
    Henegar JR; Schwartz DD; Janicki JS
    Am J Physiol; 1998 Aug; 275(2):H534-41. PubMed ID: 9683442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.
    Kabour A; Henegar JR; Devineni VR; Janicki JS
    Cardiovasc Res; 1995 Apr; 29(4):543-8. PubMed ID: 7796449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta1-adrenergic receptor blockade attenuates angiotensin II-mediated catecholamine release into the cardiac interstitium in mitral regurgitation.
    Tallaj J; Wei CC; Hankes GH; Holland M; Rynders P; Dillon AR; Ardell JL; Armour JA; Lucchesi PA; Dell'Italia LJ
    Circulation; 2003 Jul; 108(2):225-30. PubMed ID: 12847066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohumoral contributions to chronic angiotensin-induced hypertension.
    Bruner CA; Fink GD
    Am J Physiol; 1986 Jan; 250(1 Pt 2):H52-61. PubMed ID: 2867686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
    Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T
    J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
    Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
    J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo.
    Nakamura S; Nakamura I; Ma L; Vaughan DE; Fogo AB
    Kidney Int; 2000 Jul; 58(1):251-9. PubMed ID: 10886570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.
    Rocha R; Martin-Berger CL; Yang P; Scherrer R; Delyani J; McMahon E
    Endocrinology; 2002 Dec; 143(12):4828-36. PubMed ID: 12446610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.
    Qadri F; Culman J; Veltmar A; Maas K; Rascher W; Unger T
    J Pharmacol Exp Ther; 1993 Nov; 267(2):567-74. PubMed ID: 8246129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac myocyte necrosis induced by angiotensin II.
    Tan LB; Jalil JE; Pick R; Janicki JS; Weber KT
    Circ Res; 1991 Nov; 69(5):1185-95. PubMed ID: 1834362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ANG II with other growth factors on Egr-1 and matrix gene expression in cardiac fibroblasts.
    Iwami K; Ashizawa N; Do YS; Graf K; Hsueh WA
    Am J Physiol; 1996 Jun; 270(6 Pt 2):H2100-7. PubMed ID: 8764262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
    Müller DN; Mervaala EM; Dechend R; Fiebeler A; Park JK; Schmidt F; Theuer J; Breu V; Mackman N; Luther T; Schneider W; Gulba D; Ganten D; Haller H; Luft FC
    Am J Pathol; 2000 Jul; 157(1):111-22. PubMed ID: 10880382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenoreceptor blockade in angiotensin-induced hypertension: effect on rat coronary arteries and myocardium.
    Bhan RD; Giacomelli F; Wiener J
    Am J Pathol; 1982 Jul; 108(1):60-71. PubMed ID: 6124124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition and angiotensin II subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes.
    Spinale FG; Holzgrefe HH; Mukherjee R; Webb ML; Hird RB; Cavallo MJ; Powell JR; Koster WH
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1082-94. PubMed ID: 9399980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries.
    Thorup C; Kornfeld M; Winaver JM; Goligorsky MS; Moore LC
    Pflugers Arch; 1998 Feb; 435(3):432-4. PubMed ID: 9426302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II.
    Gorbea-Oppliger VJ; Fink GD
    J Pharmacol Exp Ther; 1995 May; 273(2):611-6. PubMed ID: 7752062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II modulates catecholamine release into interstitial fluid of canine myocardium in vivo.
    Farrell DM; Wei CC; Tallaj J; Ardell JL; Armour JA; Hageman GR; Bradley WE; Dell'Italia LJ
    Am J Physiol Heart Circ Physiol; 2001 Aug; 281(2):H813-22. PubMed ID: 11454586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis.
    Wenzel UO; Thaiss F; Helmchen U; Stahl RA; Wolf G
    Kidney Int; 2002 Mar; 61(3):1020-9. PubMed ID: 11849457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors.
    Maruyama R; Hatta E; Yasuda K; Smith NC; Levi R
    J Pharmacol Exp Ther; 2000 Jul; 294(1):248-54. PubMed ID: 10871319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.